From the press release: "In the first quarter we delivered significant earnings growth as a result of strong demand for products across our sequencing portfolio," stated Jay Flatley, CEO. "While the genomics market remains nascent, our best-in-class product offerings are accelerating adoption, setting the stage for a robust 2015."
ILMN closed today at $199.50. 52-week range: $128.38 - $213.33.
No comments:
Post a Comment